Cargando…
Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients
PURPOSE: Weight loss is a well-recognized prognostic parameter for survival of lung cancer patients. Computerized-tomography (CT)-based analysis of body composition and blood-based metabolic evaluation are promising prognostic tools. We aimed to assess the correlation between albumin, body mass inde...
Autores principales: | Magri, Valentina, Gottfried, Teodor, Di Segni, Mattia, Urban, Damien, Peled, Michael, Daher, Sameh, Stoff, Ronen, Bar, Jair, Onn, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733251/ https://www.ncbi.nlm.nih.gov/pubmed/31564979 http://dx.doi.org/10.2147/CMAR.S210958 |
Ejemplares similares
-
Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers
por: Daher, Sameh, et al.
Publicado: (2021) -
Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
por: Onn, Amir, et al.
Publicado: (2021) -
Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone
por: Saad, Akram, et al.
Publicado: (2022) -
Self-reported sleep quality as prognostic for survival in lung cancer patients
por: Gottfried, Teodor, et al.
Publicado: (2020) -
Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing
por: Sehayek, Or, et al.
Publicado: (2022)